Showing results (381-390 of 673) with videos related to
Sort By:
Pageof 68
HIV Clinical Trials|July 13, 2004
Determinants of sustained virological suppression in indigent, HIV-infected patients: is single protease inhibitor-based antiretroviral therapy truly highly active?F Visnegarwala, E A Graviss, P Sajja, et al.HIV Clinical Trials|November 25, 2004
Higher rates of viral suppression with nonnucleoside reverse transcriptase inhibitors compared to single protease inhibitors are not explained by better adherenceSheri D Weiser, David Guzman, Elise D Riley, et al.HIV Clinical Trials|March 15, 2005
Quadruple-drug induction HAART in advanced HIV infectionFranco Maggiolo, Diego Ripamonti, Annapaola Callegaro, et al.HIV Clinical Trials|March 6, 2004
A randomized clinical trial comparing nelfinavir and ritonavir in patients with advanced HIV disease (CPCRA 042/CTN 102)George Perez, Rodger D MacArthur, Sharon Walmsley, et al.HIV Clinical Trials|March 6, 2004
The efficacy of calcium carbonate in the treatment of protease inhibitor-induced persistent diarrhea in HIV-infected patientsMegan J Turner, Jonathan B Angel, Kirsten Woodend, et al.HIV Clinical Trials|October 9, 2004
Progression of lipodystrophy (LD) with continued thymidine analogue usage: long-term follow-up from a randomized clinical trial (the PIILR study)Allison Martin, Don Smith, Andrew Carr, et al.HIV Clinical Trials|October 9, 2004
Usefulness of therapeutic drug monitoring of antiretrovirals in routine clinical practiceMichel Duong, Anne Golzi, Gilles Peytavin, et al.HIV Clinical Trials|February 6, 2010
Virologic suppression, treatment adherence, and improved quality of life on a once-daily efavirenz-based regimen in treatment-Naïve HIV-1-infected patients over 96 weeksDushyantha Jayaweera, Edwin Dejesus, Kim L Nguyen, et al.HIV Clinical Trials|February 6, 2010
Effect of HCV infection on glucose metabolism in pregnant women with HIV receiving HAARTCarmela Pinnetti, Marco Floridia, Antonella Cingolani, et al.Pageof 68